Bruce Morimoto

Bruce Morimoto

Company: Alto Neuroscience

Job title: Vice President, Drug Development


Audience Discussion: Resetting the Regulatory Standard in Matching Measures to Patient Benefit 3:45 pm

Evaluating recent approvals in neuroscience and their impact on the field Understanding how biological markers can be implemented in approval processes What are the optimal pathways for reaching marketable drugs as research moves forward?Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.